- October 24, 2025 - Rose Pharma Inc., a clinical-stage biopharmaceutical company developing ROSE-010, a rapid-onset, short-duration GLP-1 therapy targeting both weight management and acute IBS pain, today announced that Chief Executive Officer Enda Kenny, PhD will present data from its recent clinical trial in weight management at #ObesityWeek2025 (sponsored by The Obesity Society) on Tuesday, November 4, 2025 at 7:30 p.m
These stress hormones drive cravings, blood sugar swings, insatiable appetite, body fat gain, and even reduced GLP-1 secretion
Our Vitamin B12 shot delivers a potent dose of this essential nutrient directly into your bloodstream, bypassing the digestive system and ensuring maximum absorption
Godoy, A
Understanding your result gives you a personalized starting point for a targeted lifestyle and nutrition strategy grounded in your unique genetic biology
The second most important mental disease is schizophrenia in which case The Global Burden of Disease 2000 estimates 1.1 % of all DALY and 2.8 % of the total YLD (Saraceno 2002)
